Top Markets
#1 0G 0G +45.73%
#2 Merlin's Seal BTC Merlin's Seal BTC +42.87%
#3 Useless Coin Useless Coin +30.72%
#4 SAFEcoin SAFEcoin +28.84%
#5 Dogs Dogs +24.05%
#6 Pons Pons +24.05%
#7 StonkBroker StonkBroker +21.73%
#8 ICON ICON +20.45%
#9 Zora Zora +20.32%
#10 Dash Dash +17.58%
Coin of the day
0G 0G
설정
언어
한국어
통화
USD
테마
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
주식 순위 #13229
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
주가
$4.99
시가총액
$508.03M
변동 (1일)
-2.48%
변동 (1년)
2.10%
국가
TW
거래 Ever Supreme Bio Technology Co., Ltd (6712)

카테고리

Healthcare
Ever Supreme Bio Technology Co., Ltd (6712)의 매출
Aug 2026 기준 매출 TTM: 0
Ever Supreme Bio Technology Co., Ltd의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Ever Supreme Bio Technology Co., Ltd의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH